Chapter 7 - The Undisclosed Account
By Tuesday afternoon, the administrative chaos at Hawthorne Hospital had reached a fever pitch.
The federal agents had spent the morning clearing out Thorne’s office on the tenth floor, hauling away boxes of financial documents and hard drives. The hospital board had held an emergency session behind closed doors, voting unanimously to place the entire facility under temporary receivership.
And in the middle of it all, I was sitting at the heavy mahogany desk in my new office, staring at a digital spreadsheet that didn't make any sense.
Clara stood beside me, leaning over the screen with a cup of black coffee in her hand. "The feds seized Thorne's primary offshore shell account an hour ago," she said, tapping the glass. "They recovered four million dollars of the diverted venture capital. But look at the sub-ledger attached to the secondary routing number."
I leaned in closer, squinting at the line items. "That's not corporate capital," I murmured. "That's personal asset layering."
"Exactly," Clara said. "It’s not connected to the hospital's R&D budget at all. It’s an independent trust fund set up in late 2022, funded by monthly wire transfers from an account registered under a private residential address."
I pulled up the property registry on my laptop, cross-referencing the address attached to the trust fund. The digital map zoomed in on an upscale suburban estate located just twenty minutes outside the city limits—a property owned entirely by Dr. Aris Thorne.
"Why would Thorne maintain a private trust fund completely separate from his hospital assets?" I asked, my brow furrowing. "If he was embezzling grant money, it would go into corporate shells to fund his lifestyle or buy protection from the board."
"It didn't fund a lifestyle," Clara replied quietly, sliding a secondary PDF onto my screen. "Look at the beneficiary."
My eyes scanned the legal document. The beneficiary of the trust wasn't Thorne, nor was it any corporate entity or offshore shell. It was a medical trust assigned to a long-term residential care facility in Vermont—specifically designated for experimental neurological rehabilitation and around-the-clock nursing care for a single patient: Thomas Vance, Senior.
I froze. The name on the document hit me like a physical blow.
"Thomas Vance," I whispered. "Not the structural engineer who was injured in the 2022 trial. This is his father. Or... wait."
"Look at the birth date on the intake file," Clara said grimly. "That’s not the engineer. That’s Dr. Aris Thorne’s younger brother. Who suffered a catastrophic spinal injury during an unauthorized experimental procedure back when Thorne was just a resident at Johns Hopkins."
The room seemed to grow cold. All this time, I had assumed Thorne was a ruthless corporate predator operating purely out of greed and ambition. But the financial trail told a completely different, darker story. The 2022 trial wasn't just a reckless attempt to secure venture capital for a new pediatric wing. It was a desperate, clandestine attempt by Thorne to replicate a neurological repair protocol that could save his paralyzed brother—using Hawthorne Hospital’s resources as his personal testing lab.
"If the feds find out about the personal trust, they'll seize the Vermont facility's funding," I said, looking up at Clara. "Thomas Vance’s care will be terminated immediately."
"And if we keep quiet about it, we're accessories to financial concealment of embezzled research funds," Clara pointed out, her voice filled with cautious concern. "Dr. Ellison, you're the managing director of this wing now. If you get tangled up in Thorne's family secrets, the receivership board will dissolve your contract before the week is out."
Before I could formulate a response, the intercom on my desk buzzed sharply.
"Dr. Ellison?" the front desk receptionist said, her voice tight with tension. "There’s someone in the lobby to see you. She says she’s an independent legal representative for the Thorne family... and she has an emergency injunction regarding the physical therapy wing."
May you like
I stood up, smoothing down my blazer, my hand dropping once more to my abdomen. The battle with Thorne wasn't over. It had just moved from corporate boardrooms to family legacy.
---
